Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Verstappen CC, et al. Among authors: postma tj. Drugs. 2003;63(15):1549-63. doi: 10.2165/00003495-200363150-00003. Drugs. 2003. PMID: 12887262 Review.
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial.
Vermorken JB, ten Bokkel Huinink WW, Mandjes IA, Postma TJ, Huizing MT, Heimans JJ, Beijnen JH, Bierhorst F, Winograd B, Pinedo HM. Vermorken JB, et al. Among authors: postma tj. Semin Oncol. 1995 Aug;22(4 Suppl 8):16-22. Semin Oncol. 1995. PMID: 7543699 Clinical Trial.
Paclitaxel-induced neuropathy.
Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ. Postma TJ, et al. Ann Oncol. 1995 May;6(5):489-94. doi: 10.1093/oxfordjournals.annonc.a059220. Ann Oncol. 1995. PMID: 7669713 Clinical Trial.
Long-term effects of vincristine on the peripheral nervous system.
Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ. Postma TJ, et al. J Neurooncol. 1993 Jan;15(1):23-7. doi: 10.1007/BF01050259. J Neurooncol. 1993. PMID: 8384253
Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma.
Postma TJ, van Groeningen CJ, Witjes RJ, Weerts JG, Kralendonk JH, Heimans JJ. Postma TJ, et al. J Neurooncol. 1998 May;38(1):69-75. doi: 10.1023/a:1005909318270. J Neurooncol. 1998. PMID: 9540059
Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy.
Postma TJ, Heimans JJ, Muller MJ, Ossenkoppele GJ, Vermorken JB, Aaronson NK. Postma TJ, et al. Ann Oncol. 1998 Jul;9(7):739-44. doi: 10.1023/a:1008344507482. Ann Oncol. 1998. PMID: 9739440
In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.
Verstappen CC, Geldof AA, Postma TJ, Heimans JJ. Verstappen CC, et al. Among authors: postma tj. J Neurooncol. 1999 Aug;44(1):1-5. doi: 10.1023/a:1006241622639. J Neurooncol. 1999. PMID: 10582662
Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer.
Postma TJ, Hoekman K, van Riel JM, Heimans JJ, Vermorken JB. Postma TJ, et al. J Neurooncol. 1999;45(3):241-6. doi: 10.1023/a:1006343818656. J Neurooncol. 1999. PMID: 10845395 Clinical Trial.
A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma.
Postma TJ, Heimans JJ, Luykx SA, van Groeningen CJ, Beenen LF, Hoekstra OS, Taphoorn MJ, Zonnenberg BA, Klein M, Vermorken JB. Postma TJ, et al. Ann Oncol. 2000 Apr;11(4):409-13. doi: 10.1023/a:1008376123066. Ann Oncol. 2000. PMID: 10847458 Clinical Trial.
Grading of chemotherapy-induced peripheral neuropathy.
Postma TJ, Heimans JJ. Postma TJ, et al. Ann Oncol. 2000 May;11(5):509-13. doi: 10.1023/a:1008345613594. Ann Oncol. 2000. PMID: 10907941 Review. No abstract available.
90 results
Jump to page
Feedback